Septeni Holdings (4293) · InitiativeRestated
Sale of the Healthcare Platform Business Through the Transfer of All Pharmarket Shares
First written in FY2021-Q2. 1 of 3 entries say "Achieved", first in FY2021-Q3. Latest entry: FY2021.
3entries
1years
0from disclosures
How it moved
Same theme, other companies
Sale of the Healthcare Platform Business Through the Transfer of All Pharmarket SharesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2021RestatedAnnual report
「子会社売却益（注） － 370,503」「（注） 医療プラットフォーム事業を手掛けていた株式会社Pharmarketの発行済株式の全てを2021年４月１日付で譲渡したことによるものであります。」
Pharmarket全株式の譲渡完了に伴う子会社売却益370,503千円を当期に認識した。 - FY2021-Q3AchievedAnnual report
「医療プラットフォーム事業を手掛けていた株式会社Pharmarketの発行済株式の全てを2021年４月１日付で譲渡したことによるものであります。」
Pharmarket全株式の譲渡が完了し、当第3四半期連結累計期間に子会社売却益370,503千円を認識した。 - FY2021-Q2First statedAnnual report
「On 23 March 2021, the Group resolved to transfer all issued shares of Pharmarket, a consolidated subsidiary engaged in the Medical Platform Business, to Kakuhashi Inc., and completed the transfer on 1 April 2021. As a result, other income of ¥358 million was expected to be recognized in the consolidated financial results for the third quarter of the fiscal year ending September 2021.」
Resolved to sell all Pharmarket shares to Kakuhashi Inc. on 23 March 2021 and completed the transfer on 1 April, with expected other income of ¥358 million in the third quarter.